Search for other papers by Paweł Komarnicki in
Google Scholar
PubMed
Search for other papers by Paweł Gut in
Google Scholar
PubMed
Search for other papers by Jan Musiałkiewicz in
Google Scholar
PubMed
Search for other papers by Maja Cieślewicz in
Google Scholar
PubMed
Search for other papers by Adam Maciejewski in
Google Scholar
PubMed
Search for other papers by Prachi Patel in
Google Scholar
PubMed
Search for other papers by George Mastorakos in
Google Scholar
PubMed
Search for other papers by Marek Ruchała in
Google Scholar
PubMed
-terminal pro-B-type natriuretic peptide (NT-proBNP), is a biologically inactive, 76-amino acid-long prohormone used as a diagnostic biomarker for heart failure ( 20 ). Its use as a diagnostic and prognostic biomarker has also been described in CS and CHD by a
Department of Child and Adolescent Medicine, Section of Pediatric Cardiology, University Hospital Jena, Am Klinikum, Jena, Germany
Search for other papers by Alexandra Kiess in
Google Scholar
PubMed
Search for other papers by Jessica Green in
Google Scholar
PubMed
Search for other papers by Anja Willenberg in
Google Scholar
PubMed
Search for other papers by Uta Ceglarek in
Google Scholar
PubMed
Search for other papers by Ingo Dähnert in
Google Scholar
PubMed
Department of Women and Child Health, Hospital for Children and Adolescents and Center for Pediatric Research (CPL), University of Leipzig, Liebigstrasse, Leipzig, Germany
Search for other papers by Wieland Kiess in
Google Scholar
PubMed
Department of Women and Child Health, Hospital for Children and Adolescents and Center for Pediatric Research (CPL), University of Leipzig, Liebigstrasse, Leipzig, Germany
Search for other papers by Mandy Vogel in
Google Scholar
PubMed
Introduction Cardiac biomarkers such as hs-troponin T (hs-TnT) and NT-proBNP are frequently used in clinical practice for the detection of acute and chronic cardiac stress. Troponin levels are established in the diagnostic work-up of suspected
Department of Endocrinology and Internal Medicine, Novo Nordisk A/S, NNF center for Basic Metabolic Research, Department of Clinical Biochemistry, Department of Clinical Physiology and Molecular Imaging, Department of Clinical Medicine, Aarhus University Hospital, Norrebrogade 44, DK-8000 Aarhus, Denmark
Search for other papers by Jeppe Skov in
Google Scholar
PubMed
Search for other papers by Jens Juul Holst in
Google Scholar
PubMed
Search for other papers by Jens Peter Gøtze in
Google Scholar
PubMed
Department of Endocrinology and Internal Medicine, Novo Nordisk A/S, NNF center for Basic Metabolic Research, Department of Clinical Biochemistry, Department of Clinical Physiology and Molecular Imaging, Department of Clinical Medicine, Aarhus University Hospital, Norrebrogade 44, DK-8000 Aarhus, Denmark
Search for other papers by Jørgen Frøkiær in
Google Scholar
PubMed
Search for other papers by Jens Sandahl Christiansen in
Google Scholar
PubMed
mixed model of repeated measures ANOVA was applied (subject and subject×period as random variables; group, time, and group×time as fixed variables). The P value of the interaction group×time is reported throughout. The proBNP data were logarithmically
Search for other papers by Jens P Goetze in
Google Scholar
PubMed
Search for other papers by Linda M Hilsted in
Google Scholar
PubMed
Search for other papers by Jens F Rehfeld in
Google Scholar
PubMed
Search for other papers by Urban Alehagen in
Google Scholar
PubMed
function, mitral flow E:A ratios and pulmonary venous flow patterns were analyzed and compared with age-adjusted reference values. Biochemical analyses N-terminal proBNP (NT-proBNP or proBNP 1–76) was measured on the Elecsys 2010 platform (Roche Diagnostics
Search for other papers by Ulla Schmidt in
Google Scholar
PubMed
Search for other papers by Birte Nygaard in
Google Scholar
PubMed
Search for other papers by Ebbe Winther Jensen in
Google Scholar
PubMed
Search for other papers by Jan Kvetny in
Google Scholar
PubMed
Search for other papers by Anne Jarløv in
Google Scholar
PubMed
Endocrine Unit, Department of Medicine, Endocrine Unit, Faculty of Health Sciences, Department of Medicine O, Herlev University Hospital, Herlev Ringvej, DK-2730 Herlev, Denmark
Search for other papers by Jens Faber in
Google Scholar
PubMed
known to be sensitive to changes in thyroid function, were studied (10, 11, 12, 13) . The markers include sex hormone-binding globulin (SHBG) representing liver function, N-terminal pro-brain natriuretic peptide (NT-proBNP) representing cardiac function
Frontier Science Research Center, Circulatory and Body Fluid Regulation, AIA Research Group, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan
Search for other papers by Sayaka Kawano in
Google Scholar
PubMed
Search for other papers by Yukiko Kawagoe in
Google Scholar
PubMed
Search for other papers by Kenji Kuwasako in
Google Scholar
PubMed
Search for other papers by Satoshi Shimamoto in
Google Scholar
PubMed
Search for other papers by Koji Igarashi in
Google Scholar
PubMed
Search for other papers by Mariko Tokashiki in
Google Scholar
PubMed
Search for other papers by Kazuo Kitamura in
Google Scholar
PubMed
Search for other papers by Johji Kato in
Google Scholar
PubMed
newly developed, automated, AM-specific fluorescence immunoassay. In addition to AM, we measured plasma levels of BNP and an N-terminal fragment of the BNP precursor (NT-proBNP) in order to compare gender- or BW gain-related alterations in AM with those
Search for other papers by Hugo R Ramos in
Google Scholar
PubMed
Department of Internal Medicine, Section of Metabolic Vascular Medicine, Division of Diabetes and Nutritional Sciences, Cardiovascular Endocrinology Laboratory, Faculty of Medicine, Hospital de Urgencias, National University of Córdoba, X5000 Córdoba, Argentina
Search for other papers by Andreas L Birkenfeld in
Google Scholar
PubMed
Search for other papers by Adolfo J de Bold in
Google Scholar
PubMed
Introduction Two male patients with type 2 diabetes (T2D) and coronary heart disease had plasma levels of brain natriuretic peptide (BNP) and N-terminal probrain natriuretic peptide (NT-proBNP) measured as part of routine evaluation. Both were
Search for other papers by Thera P Links in
Google Scholar
PubMed
Search for other papers by Trynke van der Boom in
Google Scholar
PubMed
Search for other papers by Wouter T Zandee in
Google Scholar
PubMed
Search for other papers by Joop D Lefrandt in
Google Scholar
PubMed
controls Klein Hesselink (2015) (23) 518 DTC patients Increased risk atrial fibrillation, independent from established AF risk factors Retrospective 1563 controls Klein Hesselink (2017) (39) 266 DTC patients NT-proBNP levels
Search for other papers by Akinori Sairaku in
Google Scholar
PubMed
Search for other papers by Yukiko Nakano in
Google Scholar
PubMed
Search for other papers by Yuko Uchimura in
Google Scholar
PubMed
Search for other papers by Takehito Tokuyama in
Google Scholar
PubMed
Search for other papers by Hiroshi Kawazoe in
Google Scholar
PubMed
Search for other papers by Yoshikazu Watanabe in
Google Scholar
PubMed
Search for other papers by Hiroya Matsumura in
Google Scholar
PubMed
Search for other papers by Yasuki Kihara in
Google Scholar
PubMed
.65 Left ventricle end-systolic volume (mL) 39 ± 13 45 ± 17 0.1 Inter-ventricular septal thickness (mm) 9.3 ± 1.7 9.1 ± 1.2 0.47 Left ventricular ejection fraction (%) 61 ± 6 58 ± 7 0.01 NT pro-BNP (pg/mL) 174 (63
Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK
Search for other papers by Richard P Steeds in
Google Scholar
PubMed
Search for other papers by Vandana Sagar in
Google Scholar
PubMed
Search for other papers by Shishir Shetty in
Google Scholar
PubMed
Search for other papers by Tessa Oelofse in
Google Scholar
PubMed
Search for other papers by Harjot Singh in
Google Scholar
PubMed
Search for other papers by Raheel Ahmad in
Google Scholar
PubMed
Search for other papers by Elizabeth Bradley in
Google Scholar
PubMed
Search for other papers by Rachel Moore in
Google Scholar
PubMed
Search for other papers by Suzanne Vickrage in
Google Scholar
PubMed
Search for other papers by Stacey Smith in
Google Scholar
PubMed
Search for other papers by Ivan Yim in
Google Scholar
PubMed
Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK
Search for other papers by Yasir S Elhassan in
Google Scholar
PubMed
Search for other papers by Hema Venkataraman in
Google Scholar
PubMed
Search for other papers by John Ayuk in
Google Scholar
PubMed
Search for other papers by Stephen Rooney in
Google Scholar
PubMed
Department of Hepatology and Liver Transplantation, University Hospitals Birmingham (Queen Elizabeth), NHS Hospitals Foundation Trust, Birmingham, UK
Search for other papers by Tahir Shah in
Google Scholar
PubMed
). Electrocardiography ( Fig. 2 ) and chest radiography ( Fig. 3 ) are also unhelpful in the majority of patients with CHD, as changes are non-specific and often only detect advanced disease. N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a useful biomarker